IP Library Granted Patent US 8,563,304
Granted Patent B2
US 8,563,304 · App. 13/160,002 · Granted Oct 22, 2013

Low oxygen culture conditions for maintaining retinal progenitor cell multipotency

Inventors: Michael J. Young (Gloucester, MA); Budd A. Tucker (Coralville, IA); Petr Y. Baranov (Somerville, MA)
Assignee: The Schepens Eye Research Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,563,304
App. No.
13/160,002
Granted
Oct 22, 2013
Kind
B2
Abstract

The present invention relates to methods for culturing human retinal progenitor cells under low oxygen conditions to allow the cells to retain the ability to differentiate into photoreceptors following transplantation. The described methods provide cells that can treat a number of ocular diseases, including retinitis pigmentosa and age-related macular degeneration.

Claims (12)

1. A method of expanding multipotent human retinal progenitor cells in vitro and maintaining the multipotency of said cells in vivo, said method comprises the steps of

establishing a cell culture comprising isolated retinal multipotent progenitor cells, and

culturing said cells under low oxygen conditions of from about 1% to about 6% oxygen content of the culture medium and for an effective amount of time while maintaining multipotency of said cells to provide an expanded population of multipotent retinal progenitor cells,

wherein said retinal progenitor cells express both express both HIF1 alpha and HIF2 alpha.

2. The method of claim 1 further comprising isolating the expanded population of cells from the culture media.

3. The method of claim 2 further comprising transplanting said cells into a host.

4. The method of claim 3 further comprising measuring said cells cultured under low oxygen conditions for multipotency.

5. The method of claim 1 further comprising culturing said cells in the presence of at least one exogenous growth factor.

6. The method of claim 1 wherein the effective amount of time comprises at least 10 passages in the low oxygen conditions.

7. The method of claim 1 wherein the oxygen content of the culture medium is from about 2% to about 4%.

8. The method of claim 1 where the retinal progenitor cells are obtained from post-natal retinal tissue.

9. The method of claim 1 wherein the retinal progenitor cells are obtained from the retinal neurosphere.

Assignments (2)
LICENSE Recorded Sep 17, 2018
From: THE SCHEPENS EYE RESEARCH INSTITUTE
To: RENEURON LIMITED
Reel/Frame 047099/0078 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2011
From: YOUNG, MICHAEL J.; TUCKER, BUDD A.; BARANOV, PETR Y.
To: THE SCHEPENS EYE RESEARCH INSTITUTE
Reel/Frame 026441/0937 →
Continuity (1)
Related Publication 20120321593A1 · Dec 20, 2012